Acosta-Jiménez E, Varela-Fascinetto G, Valencia-Mayoral P

Language: Spanish
References: 18
Page: 132-140
PDF size: 355.08 Kb.

ABSTRACT

Introduction. Vascular lesions of the liver are varied and may be observed in different conditions; arterial lesions have been observed in extrahepatic biliary atresia (EBA). To our knowledge, alterations of the portal vein or its main branches have not been described previously. The aim of this article is to inform peculiar portal vein lesions found in a group of patients with EBA.
Methods. This is a descriptive, retrospective study of 62 consecutive biopsies of patients with EBA who underwent porto-enteral anastomosis over a 10 year period. Vessels from the hepatic hilium were studied with hematoxylin & eosin, Masson’s trichrome, elastic fibers, mucicarmine, alcian blue, PAS, coloidal iron, CD20, CD3, CD68, and actin stains. Cellular or fibrous sub-endothelial proliferation, tunica elastic damage, edema, calcification, thrombosis, and glycosaminoglycan deposits were searched; the extension of damage was graded as mild (less than 25% of circumference), moderate (26 to 50%), or severe (over 50%). Vessels were classified according to their circumference as medium sized (less than 300 microns) and large; when possible the portal vein and/or its larger branches were evaluated. Hepatic explants (n =20) of patients without EBA were used as a controls. Demographic data were obtained from clinical charts.
Results. Age averaged 3 months; 45 patients were female. In 24 cases, portal vein or its larger branches were present. Vascular alterations were observed in 35 cases: arterial changes in 13, vein lesions in 10, and both types of damage in 12. The main arterial changes found were: elastic rupture (n =19), glycosaminoglycans deposits (n =19), and sub-endothelial cellular proliferation (n =20); all changes were mild to moderate. On the other hand, glycosaminoglycans deposits (n =7), sub-endothelial fibrous proliferation (n =8), and elastic fibers rupture (n =9) were the main alterations observed in the portal vein or its branches; these changes were mild. Sub-endothelial cellular proliferation was composed of macrophages, B and T lymphocytes, and myofibroblasts. These alterations were present since early ages and not observed in control subjects.
Conclusions. Vascular alterations were commonly observed in EBA. Portal vein changes were present at least in one third of cases studied, and they appear to be part of the process and not an acquired condition. These changes may explain some vascular complications of liver transplantation of patients with EBA as well as support vascular and/or autoimmune theories on EBA origin; likewise, they may provide data for future insights on EBA pathogenesis.

REFERENCES

1. Balistreri WF. Neonatal cholestasis: Lesson from the past, issues for the future. Semin Liver Dis. 1987; 7: 61-6.

2. Karrer FM, Bensard DD. Neonatal cholestasis. Semin Pediatr Surg. 2000; 4: 166-9.

3. Bousvaros A, Locaille F, Lillehei C. Colestasis neonatal. Int Semin Pediatr Gastroenterol Nutr. 1999; 3: 1-11.

4. Sokol R, Mack C, Narkewicz MR, Karrer FM. Pathogenesis and outcome of biliary atresia: Current concepts. J Pediatr Gastroenterol Nutr. 2003; 1: 4-21.

5. Jonas MM, Pérez-Atayde AR. Liver diseases in infancy and childhood. En: Schiff ER, Sorrell MF, Maddrey WC, editores. Schiff´s diseases of the liver. Philadelphia: Lippincott Williams Wilkins; 2007. p. 1305-43.

6. Russo PA, Mitchell GA, Tanguay RM. Tyrosinemia: A review. Pediatr Dev Pathol. 2001; 4: 212-21.

7. Knisely AS. Progressive familial intrahepatic cholestasis: A personal perspective. Pediatr Dev Pathol. 2000; 3: 113-25.

8. Bove KE, Daugherty CC, Tyson W, Mieray G, Heubi JE, Balistreri W. Bile acid synthetic defects and liver disease. Pediatr Dev Pathol. 2000; 3: 1-16.

9. Phillips J, Blendis L, Poucell S, Patterson J, Petric M, Robert E. Syncitial giant cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course and paramyxoviral features. N Engl J Med. 1991; 7: 455-60.

10. Kahn E. Biliary atresia revised. Pediatr Dev Pathol. 2004; 7: 109-24.

11. Kobayashi H, Li Z, Yamataka A, Lane GJ, Miyano T. Role of immunologic costimulatory factors in the pathogenesis of biliary atresia. J Pediatr Surg. 2003; 6: 892-6.

12. Chardot C, Carton M, Spire-Bendelac N, Le PC, Golmard JL, Auvert B. Prognosis of atresia in the era of liver transplantation: French National Study from 1986 to 1996. Hepatology. 1999; 3: 606-11.

13. Klippel CH. A new theory of biliary atresia. J Pediatr Surg. 1972; 6: 651-4.

14. Ho CW, Shioda K, Shirasaki K, Takahashi S, Tokimatsu, Maeda K. The pathogenesis of biliary atresia: A morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr. 1993; 1: 53-60.

15. Liu G, Butany J, Wanless IR, Cameron R, Greig P, Levy G. The vascular pathology of human hepatic allograft. Hum Pathol. 1993; 2: 182-8.

16. Wanless IR, Bernier V, Seger M. Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study. Am J Pathol. 1982; 106: 63-70.

17. Balistreri WF. Liver diseases in infancy and childhood. En: Shiff ER, Sorrell MF, Maddrey WC, editores. Disease of the liver. 8a ed. New York: Lippincott Raven; 1999. p. 1357-512.

18. Ishak KG. Developmental abnormalities and liver disease in childhood. En: MacSween RNM, Burt AD, Portmann BC, editores. Pathology of the liver. 4a ed. London: Churchill Livingstone; 2002. p. 107-54.